Condition 1: Mood disorders. Condition 2: Sleep disorders. Persistent mood [affective] disorders Sleep disorders
Conditions
Interventions
Intervention 1: Intervention group: For 8 weeks, they received Karen Company creatine (5 grams daily after training, also used on non-training days) along with an isocaloric diet (with the same percen
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 48 Years
Inclusion criteria
Inclusion criteria: Healthy adults (male and female) aged 18-48 years Healthy active adults with at least 3 months of resistance exercise (bodybuilding) history Resident of Tehran
Exclusion criteria
Exclusion criteria: The presence of metabolic diseases such as diabetes and high blood pressure, viruses such as influenza and coronavirus, and musculoskeletal diseases such as osteoporosis and rheumatoid arthritis. Taking medications that cause changes in metabolism and absorption: such as diuretics, amphetamines, thyroid hormones, topiramate, orlistat, and corticosteroids Following specific diets and taking dietary, exercise, and caffeine supplements Participation in professional sports Pregnant and breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phase angle score. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Bioimpedance.;Pittsburgh Questionnaire Score. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Pittsburgh Questionnaire Score.;Brums Questionnaire Score. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Brums 32-questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist Circumference. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Non-stretching tape measure.;Body Mass Index. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Dividing the weight into kilograms by squared height meters.;Body fat percentage. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Bioimpedance.;Physical activity. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Met-International Physical Activity Questionnaire.;Total body water. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Bioimpedance.;Intracellular water. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Bioimpedance.;Extracellular water. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Bioimpedance.;Lean body mass. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Bioimpedance. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Kurosh Djafarian
Tehran University of Medical Sciences
Outcome results
None listed